Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early ivabradine after PCI for acute anterior myocardial infarction with early heart failure
ChiCTR2000032731Phase 4Not yet recruiting
- Sponsor
- Central Hospital of Shanghai Putuo District
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ivabradine in anterior myocardial infarction (AWMI) and heart failure (HF) (2 arms), sponsored by Central Hospital of Shanghai Putuo District. Primary endpoint: Left ventricular end diastolic volume. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
anterior myocardial infarction (AWMI)heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2000032731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032731.